Tarsus Pharmaceuticals (TARS) Earnings Date & Reports
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TARS is expected to report earnings to fall 41.25% to -28 cents per share on November 05
Q3'25
Est.
$-0.28
Q2'25
Missed
by $0.10
Q1'25
Beat
by $0.15
Q4'24
Beat
by $0.17
Q3'24
Beat
by $0.33
The last earnings report on August 06 showed earnings per share of -47 cents, missing the estimate of -37 cents. With 479.32K shares outstanding, the current market capitalization sits at 2.02B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TARS showed earnings on August 06, 2025. You can read more about the earnings report here.